| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8787531 | Journal of Thoracic Oncology | 2018 | 8 Pages |
Abstract
An accurate definition of the criteria to determine the PD-L1 status of a given tumor may greatly help in selecting those patients who could benefit from anti-programmed cell death 1/PD-L1 treatment.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Enrico MD, PhD, Giuseppe MD, Gianluigi MPharm, Luigi MD, PhD, Marcella BS, Marco BS, Matteo MD, PhD, Guido MD, George J. MD, Mohammad O. PhD, Francesca MD, Maria Cristina PhD, Maria Cristina MD, Alessandro MD, Simona MD, Alberto MD, Alberto MD,